News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Vincent Rajkumar: Introducing a one-stop site to estimate risk of progression in myeloma.
Photo of Vincent Rajkumar from healthtree.org
Sep 16, 2023, 17:55

Vincent Rajkumar: Introducing a one-stop site to estimate risk of progression in myeloma.

Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently shared on X/Twitter:

“MyelomaRisk.com
Introducing a one-stop site to estimate risk of progression in myeloma, SMM, MGUS. Bookmark it!
Link to the website and an alternate link.

Source: Vincent Rajkumar/Twitter

cancer E. Amadou Touré Myeloma OncoDaily Oncology Shaji Kumar Vincent Rajkumar
Blog
Jul 3, 2024, 23:31
A few papers to read about Precision oncology and use of AI suggested by Vivek Subbiah
Insight
Jul 3, 2024, 23:28
Neeraj Agarwal: Amazing performance by the stellar Genitourinary Cancer Research Team's junior investigators
Blog
Jul 3, 2024, 22:59
Aleix Prat: Our 2 articles published this week
Blog
Jul 3, 2024, 22:53
Naveen Pemmaraju congratulates new interns, reflecting back on his first year
Blog
Jul 3, 2024, 22:50
How much do doctors think about their patients?
Positive
Jul 3, 2024, 22:48
Feyikemi (Kemi) Osundina: Sanofi's 40 year global anniversary of partnership within the transplant community
Societies
Jul 3, 2024, 22:39
Upcoming July events from NCI
Insight
Jul 3, 2024, 22:27
Riya Patel: GI Highlights at the Upstate NY Cancer Symposium 2024, hosted by The Oncology Brothers
Blog
Jul 3, 2024, 22:23
European Cancer Organisation - Sign up to the INTERACT- EUROPE 100 training
Blog
Jul 3, 2024, 22:09
The EACR’s first time at the FEBS2024 Congress exhibition
Blog
Jul 3, 2024, 22:02
Sawsan AlMadhi: Zainab Shinkafi-Bagudu is a true leader and advocate for women's health and cancer
Blog
Jul 3, 2024, 21:59
SIOPE - Risks and ethical considerations of involving children and adolescents in clinical trials